HEP Fund, Author at HEP Fund

Q&A with Clay Ritchey, CEO of Evariant

HEP Fund2024-03-21T13:49:18+00:00September 29th, 2017|

Clay Ritchey is the Chief Executive Officer of Evariant. Clay has more [...]

HEP Fund2024-03-21T13:49:36+00:00August 10th, 2017|

Establishing a home infusion brand and quickly growing it to become one [...]

HEP Fund2024-03-21T13:49:58+00:00June 13th, 2017|

Jon Hunt is the President and CEO of Bardy Diagnostics Prior to [...]

HEP Fund2020-09-09T15:14:42+00:00May 30th, 2017|

ContinuumRX & Inova Health System have formed a joint healthcare venture aimed at [...]

HEP Fund2020-09-09T15:12:11+00:00April 4th, 2017|

Evariant announced that it has appointed Clay Ritchey as Chief Executive Officer. [...]

HEP Fund2024-03-21T13:42:48+00:00March 13th, 2017|

Steve Lefar is the CEO of Applied Pathways. Steve was formerly the [...]

HEP Fund2020-09-09T15:12:27+00:00January 18th, 2017|

Jet Health, Inc. announced the acquisition of Colorado based Home Health Investments, [...]

HEP Fund2020-09-09T15:12:37+00:00January 5th, 2017|

Bardy Diagnostics announced that it has raised a significant round of growth [...]

HEP Fund2020-09-09T15:12:47+00:00November 2nd, 2016|

Catapult Health announced the completion of a $10M Series B financing which [...]